Mariana M. P.
- Country
- Bulgaria
- Department
- N/A
Research Overview
- A Phase 3b Long-term Efficacy and Safety Extension Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria
- Noninferiority of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide versus beclometasone dipropionate/formoterol fumarate in asthma
- Long-term safety of remibrutinib in patients with chronic spontaneous urticaria continuing from prior remibrutinib treatment trials
Data & Insights
Has run more than one trial at 152 of 379 partner sites.
Specializations
Dermatological Research
The investigator specializes in studying chronic inducible urticaria, focusing on innovative therapeutic approaches for this challenging skin condition.
- Cold-induced urticaria management
- Symptomatic dermographism treatment
- H1-antihistamine refractory conditions
Their research interest extends to understanding treatment responses in patients with refractory forms of urticaria.
Immunological Studies
The investigator focuses on immunological mechanisms underlying chronic urticaria conditions and their therapeutic interventions.
- Novel biological therapies
- Immune response modulation
- Treatment-resistant cases
Their work explores new therapeutic pathways for managing immune-mediated skin disorders.
Clinical Therapeutics
The investigator evaluates novel treatment approaches for chronic urticaria, with particular attention to dose optimization and therapeutic efficacy.
- Dose-ranging studies
- Treatment efficacy assessment
- Safety profile evaluation
Their research aims to advance understanding of therapeutic responses in chronic urticaria patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.